ALERGIA-N¼ 4/P. ENCUENTRO - Alergología e Inmunología Clínica

Nœm. 4 Utilidad de la cuantificaci—n de la triptasa 265
40. Randall B, Butts J, Halsey JF. Elevated postmortem
tryptase in the absence of anaphylaxis. J Forensic
Sci 1995; 40: 208-211.
41. Schwartz HJ, Yunginger JW, Schwartz LB. Is unrecognized
anaphylaxis a cause of sudden unexpected
death? Clin Exp Allergy 1995; 25: 866-870.
42. Edston E, Van Hage-Hamsten, Johanson SGO.
Tryptase at last a useful diagnostic marker for
anaphylactic deatk. Allergy 1996; 51: 443-445.
43. Platt MS, Yunginger JW, Sekula-Perlman A, Irani
AMA, Smialek J, Chandani HG, et al. Involvement
of mast cells in sudden infant death syndrome. J
Allergy Clin Immunol 1994; 94: 250-256.
44. Holgate ST, Walters C, Walls AF, Lawrence S,
Shell DLJL, Variend S, et al. The anaphylaxis
hypotesis of sudden infant death syndrome (SIDS):
mast cell degranulation in col death revealed by
elevated concentration of tryptase in serum. Clin
Exp Allergy 1994; 24: 1115-1122.
45. Alter SC, Kramps JA, Janoff A, Schwartz LB. Interactions
of human mast cell tryptase with biological
protease inhibitors. Arch Biochem Biophys
1990; 2767: 26-30.
46. Ebbeling WL, Schwartz LB, Buckley RW. Comparison
of plasma histamine and tryptase levels following
double-blind and placebo-controlled food
challenges in patients with asthma and/or atopic
dermatitis. J Allergy Clin Immunol 1988; 81: 69.
47. Laroche D, Dubois F, Lefran ois C, Vergnaud MC,
GŽrard JL, Soufarapis H, et al. Marqueurs biologiques
prŽcoces des rŽactions anaphylacto•des peranesthŽsiques.
Ann Fr Anesth Reanim 1992; 11: 613-618.
48. Laroche D, Lefran ois C, GŽrard JL, Dubois F,
Vergnaud MC, GuŽant JL, et al. Early diagnosis of
anaphylactic reactions to neuromuscular blocking
drugs. Br J Anaesth 1992; 69: 611-614.
49. Laroche D, Vergnaud MC, Sillard B, Soufarapis H,
Bricard H. Biochemical markers of anaphylactoid
reactions to drugs. Anesthesiology 1991; 75: 945-949.
50. Fisher M, Baldo BA. The diagnosis of fatal
anaphylactic reactions during anaesthesia: employment
of inmunoassays for mast cell tryptase and
drug-reactive IgE antibodies. Anaesth Intens Care
1993; 21: 353-357.
51. Volcheck GW, Li JTC. Elevated serum tryptase level
in a case of intraoperative anaphylaxis caused by latex
allergy. Arch Intern Med 1994; 154: 2243-2245.
52. Blanco J, Cardenas E, Aguilera L, Camino E, Arizaga
A, Telletxea S. Serum tryptase measurement in diagnosis
of intraoperative anaphylaxis caused by hydatid
cyst. Anaesth Intens Care 1996; 24: 489-491.
53. Saitoh J, Mitsuhata H, Horiguchi Y, Saitoh K,
Fukuda H, Shimizu R. Usefulness of measurement
of mast cell tryptase for diferencial diagnosis of
75
anaphylasis and anaphylactoid reaction. Masui
1995; 44/9: 1265-1268.
54. Takenoshita M, Sugiyama M, Okuno Y, Dnagaki Y,
Yoshiya I, Shimazaki Y. Anaphylactoid reaction to
portaren confirmed by plasma tryptase in a diabetic
patient during open heart surgery. Anaesthesiol
1996; 84: 233-235.
55. Weiss ME, Nyhan D, Peng Z, Horrow JC, Lowenstein
E, Hirshman C, Adkinson NF. Association of
protamine IgE and IgG antibodies with life-threatening
reactions to intravenous protamine. N Eng J
Med 1989; 320: 886-892.
56. Matsson P, Enander I, Andersson AS, Nystrand J,
Schwartx LB, Watkins J. Evaluation of mast cell
activation (tryptase) in two patients suffering from
drug-induced hypotensoid reactions. Agents Action
1991; 33: 218-220.
57. Cottineau C, Drouet M, Costerousse F, Dussaussoy C,
Sabbah A. IntŽret del mŽdiateurs plasmatiques (histamine
et tryptase) et urinaire (mŽtilhistamine) lors des
rŽaction, anaphylactiques et ou anaphylactoides peranesthŽsiques.
Allerge Immunol 1996; 28: 270-276.
58. Benson MD, Lindberg RE. Amniotic fluid embolism,
anaphylaxis and tryptase. Am J Obstet Gynecol
1996; 175: 737.
59. Guilloux L, Ricard-Blijm S, Ville G, Motin J. Histamine
release assay and radioimmunoassay for the detection
of IgE antibodies against neuromuscular blocking
drugs. Ann Fr Anesth Reanim 1993; 12: 182-186.
60. Laxenaire MC, Charpentier C, Feldman L.
Anaphylactoid reactions to colloid plasma substitute:
frequency, risk factors, mechanisms. A French
prospective multicentre inquiry. Ann Fr Anesth
Reanim 1994; 13: 301-310.
61. Marone G, Patella V, Crescenzo G, Genovese A,
Adt M. Human heart mast cells in anaphylaxis and
cardiovascular disease. Int Arch Allergy Immunol
1995; 107: 72-75.
62. Watkins J, Wild G. Improved diagnosis of anaphylactoid
reactions by measurement of serum tryptase
and urinary methilhistamine. Ann Fr Anesth Reanim
1993; 12: 169-172.
63. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman
B, Worobec AS, et al. The alfa-form of human tryptase
is the predominant type present in blood at baseline
in normal subjects and is elevated in those with systemic
mastocytosis. J Clin Invest 1995; 96: 2702-2710.
64. Smith CH, Kepley CH, Schwartz LB, Lee TH. Mast
cell number and phenotype in chronic idiopathic urticaria.
J Allergy Clin Immunol 1995; 96: 360-364.
65. Irani AA, Garriga MM, Metcalfe DD, Schwartz LB.
Mast cells in cutaneous mastocytosis: accumulation of
the MCtc type. Clin Exp Allergy 1990; 20: 53-58.
66. Pumphrey RSP, Stanworth SJ. The clinical spec-